PyAMPA: a high-throughput prediction and optimization tool for antimicrobial peptides
Open Access
- 23 July 2024
- journal article
- research article
- Published by American Society for Microbiology in mSystems
- Vol. 9 (7) , e0135823
Abstract
The alarming rise of antibiotic-resistant bacterial infections is driving efforts to develop alternatives to conventional antibiotics. In this context, antimicrobial peptides (AMPs) have emerged as promising candidates for their ability to target a broad range of microorganisms. However, the development of AMPs with optimal potency, selectivity, and/or stability profiles remains a challenge. To address it, computational tools for predicting AMP properties and designing novel peptides have gained increasing attention. PyAMPA is a novel platform for AMP discovery. It consists of five modules, namely AMPScreen, AMPValidate, AMPSolve, AMPMutate, and AMPOptimize, that allow high-throughput proteome inspection, candidate screening, and optimization through point-mutation and genetic algorithms. The platform also offers additional tools for predicting and evaluating AMP properties, including antimicrobial and cytotoxic activity, and peptide half-life. By providing innovative and accessible inroads into AMP motifs in proteomes, PyAMPA will enable advances in AMP development and potential translation into clinically useful molecules. PyAMPA is available at: https://github.com/SysBioUAB/PyAMPA IMPORTANCE: This paper introduces PyAMPA, a new bioinformatics platform designed for the discovery and optimization of antimicrobial peptides (AMPs). It addresses the urgent need for new antimicrobials due to the rise of antibiotic-resistant infections. PyAMPA, with its five predictive modules -AMPScreen, AMPValidate, AMPSolve, AMPMutate and AMPOptimize, enables high-throughput screening of proteomes to identify potential AMP motifs and optimize them for clinical use. Its unique approach, combining prediction, design, and optimization tools, makes PyAMPA a robust solution for developing new AMP-based therapies, offering a significant advance in combatting antibiotic resistance.Keywords
Funding Information
- Ministerio de Ciencia e Innovación (PID2020-114627RB-I00/AEI/10.13039/501100011033)
- Ministerio de Ciencia e Innovación (PDC2021-121544-I00/AEI/10.13039/501100011033)
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID2022)
- Ministerio de Ciencia e Innovación (PID2020-113184RB-C22/AEI/10.13039/501100011033)
- La Caixa Health Foundation (HR17-00409)
This publication has 42 references indexed in Scilit:
- AMP‐BERT: Prediction of antimicrobial peptide function based on a BERT modelProtein Science, 2022
- Rationally Modified Antimicrobial Peptides from the N-Terminal Domain of Human RNase 3 Show Exceptional Serum StabilityJournal of Medicinal Chemistry, 2021
- Antimicrobial Resistance in Bacteria: Mechanisms, Evolution, and PersistenceJournal of Molecular Evolution, 2019
- KELM-CPPpred: Kernel Extreme Learning Machine Based Prediction Model for Cell-Penetrating PeptidesJournal of Proteome Research, 2018
- IRGB10 Liberates Bacterial Ligands for Sensing by the AIM2 and Caspase-11-NLRP3 InflammasomesCell, 2016
- Prediction of cell-penetrating peptides with feature selection techniquesBiochemical and Biophysical Research Communications, 2016
- Access to effective antimicrobials: a worldwide challengeThe Lancet, 2016
- Prediction of Bioactive Peptides Using Artificial Neural Networks2014
- Refining the Eosinophil Cationic Protein Antibacterial Pharmacophore by Rational Structure MinimizationJournal of Medicinal Chemistry, 2011
- Global trends in emerging infectious diseasesNature, 2008